RE:RE:RE:RE:RE:RE:RE:RE:RE:Very strange , even for ONC The important stuff?
Oncolitics biotech is in deep with a Roche.
The Gobblet trivial started a few years ago. Now seeing progress
recently & in Onc or any biotech world, getting FDA fast track recognition to adnave to phase 3 with the Pancreatic cancer arm. And moving forward with most recent tye anal cancer arm.
The third arm I can't recall. Perhaps those who spend countless hours correcting me, can validate the 3 rd opportunity they are progressing along with Roche ( tecentriq co- therapy).?
Regarding the Microsoft to Onc comparison? Not at all insinuating they are remotely the same.
The investment advice however is the same. Bill gates divested billions from Microsoft. Not because he had misgivings towards the company. Simple ( perhaps complicated for the likes of those who can't get beyond finding faults with meaningless statements) .. logic.
simple logic.
Too many eggs in one basket, regardless of the basket size or contents.
i have never disclosed before. A few on here know me personally & have talked email & phone.
I was raised very poor. Single mom, back before it was common.
Today? My professionaly managed portfolio in excess of $1.3 million.Onc is not part of that.
I do dabble in a few stocks.
onc being one of a handful...I have been using my dividends from my blue chip stocks to buy more Onc.
averaging down.
Should Onc fail, I'll be disappointed, but I won't be broke, or even miss a meal.
Should they get Pela to market and/ or a buyout. I'll be quite happy.
Probably buy a Tesla, or two. Cars not stocks lol
bottom line for me?
I believe in Onc, it's product Pelareorep.
Roche would not put their good name into a 4 arm trial. Now advancing to next phases in 3 of the arms, without strong clinical evidence.
onc mangement? Easy to throw stones.
onc mangement arranged a great deal with PanCan,.
That deal was cancelled not by Onc or because of ONC....PanCan essentially closed down. The precision promise program.
Putting Onc into a very difficult situation at a very bad time.
none of the science has changed.
The FDA fast track for MBc & panc cancers still exists.
What is not in place is the $$$ to move forward.
THAT is all that matters going forward, Not who said what or when in this board or any. Not if people have projected buyouts in many billions or complete failures.
The answer MUST come to light , very soon.
predict, bash, promote, put down, all you want.
none of it matters.
new investors?
Those who bought in on the last dip a week or so ago, are up a reasonable %.
question then becomes, where is the upside?
Im in for the long haul. Good news & I come into @ lot of extra spending $$.
bad news?
Money I have already spent.
great day all.
again a challenge for those who work so hard at correcting me.
please update on the 3rd arm of the Gobblet trial, that was successful.
Two being Pancreatic & Anal.
i just can't remember.
regards